Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AML

Affiliations

• ¹ Cancer and Hematology Center, Vestfold Hospital Trust, Tønsberg, Norway.
• ² Medical Department, Drammen Hospital, Vestre Viken Trust, Drammen, Norway.
• ³ Department of Pathology, and Institute of Clinical Medicine, The Medical Faculty, Oslo University Hospital, University of Oslo, Oslo, Norway.
• ⁴ Department of Hematology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
• ⁵ Oslo Centre of Biostatistics and Epidemiology Department for Research and Education, Division of Mental Health and Addiction Oslo University Hospital, Oslo, Norway.
• ⁶ Department of Hematology, Lovisenberg Hospital, Oslo, Norway.
• ⁷ Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.
• ⁸ Consultant Department of Hematology, Central Hospital Østfold Kalnes, Grålum, Norway.
• ⁹ Medical Department, Sorlandet Hospital HF, Kristiansand, Norway.
• ¹⁰ Hematological Department, University Hospital of North Norway, Tromsø, Norway.
• ¹¹ Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
• ¹² Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden.
• ¹³ Clinical Research Unit, Pharmacological Department, Oslo University Hospital, Oslo, Norway.